𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-Effectiveness of Clinical Breast Assessment-Based Screening in Rural Egypt

✍ Scribed by Adel Denewer; Osama Hussein; Omar Farouk; Waleed Elnahas; Ashraf Khater; Aiman El-Saed


Publisher
Springer
Year
2010
Tongue
English
Weight
204 KB
Volume
34
Category
Article
ISSN
0364-2313

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The cost-effectiveness of nationwide bre
✍ Tiina Leivo; Harri Sintonen; Risto Tuominen; Matti Hakama; Eero Pukkala; Olli-Pe πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 93 KB πŸ‘ 2 views

The aim of this study was to evaluate the cost-effectiveness, from a societal perspective, of the Finnish nationwide breast carcinoma screening program. ## METHODS. The effects were measured in life-years saved from 1987 to 2020, using data from the nationwide program to the end of 1992. A total o

Economic analysis of outreach assessment
✍ M. M. van der Pol; J. A. Cairns; F. J. Gilbert; P. J. Hendry πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

A model is developed for the economic evaluation of outreach assessment clinics following screening and used to identify the cost-minimizing strategy for assessing women from three island communities in the Scottish Breast Screening Programme (SBSP). There are four options of interest depending on:

Prediction of the effects and costs of b
✍ Petra M. M. Beemsterboer; Harry J. De Koning; Peter G. Warmerdam; Rob Boer; Enno πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 743 KB

Although breast-cancer screening programmes are now being introduced it is still debated whether this is an appropriate policy for all European countries. Taking into account empirical data from 2 regional pilot screening projects, this study has evaluated the effects and costs of a nationwide breas

Exploring the cost-effectiveness of Heli
✍ Jennifer M. Yeh; Karen M. Kuntz; Majid Ezzati; Sue J. Goldie πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 344 KB

## Abstract Gastric cancer is the second leading cause of cancer‐related deaths worldwide. Treatment for __Helicobacter pylori__ infection, the leading causal risk factor, can reduce disease progression, but the long‐term impact on cancer incidence is uncertain. Using the best available data, we es